VTRS
VTRS
NASDAQ · Pharmaceuticals

Viatris Inc

S&P 500 Large-Cap Stocks Blue Chip Stocks Pharmaceutical Stocks Healthcare Stocks Best Dividend Stocks
$17.20
+0.25 (+1.47%)
Analyst Consensus
Buy
17
Analysts
High
Coverage
Buy 11 65%
Hold 5 29%
Sell 1 6%
Price Target
Analyst Price Target +614.1% upside
Low Target $69.38
Average Target $122.82
High Target $167.78
Current Price $17.20
Current
$17.20
Target
$122.82
$69.38 $122.82 avg $167.78
Scenario Analysis
Bear Case
$69.38
303.4%
Low target
Base Case
$122.82
+614.1%
Avg target
Bull Case
$167.78
+875.5%
High target
Risk/Reward
2.9x
Favorable
Price in Context
52-Week High
$18.39
-6.5% from high
52-Week Low
$9.43
+82.4% from low
50-Day SMA
$13.14
+30.9% vs SMA
200-Day SMA
$10.55
+63.0% vs SMA
RSI (14)
87.6
Overbought
Target vs 52W High
$122.82
+567.9% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
 Strong Buy 38 79% $1,330.33 +14.0%
RDY
Dr. Reddy's Laboratories
 Strong Sell 45 31% — +0.0%
JNJ
Johnson & Johnson
 Buy 31 71% $299.55 +10.5%
MRK
Merck & Co. Inc.
 Buy 36 72% $159.27 +6.1%
PFE
Pfizer Inc.
 Hold 36 39% $33.90 +21.5%
BMY
Bristol-Myers Squibb Co
 Hold 35 43% $174.50 +177.1%
RPRX
Royalty Pharma Plc- Cl A
 Strong Buy 16 88% $36.26 -37.9%
ZTS
Zoetis Inc
 Hold 24 50% $209.87 +192.3%